Medicine and Dentistry
Mir-145
100%
Obstetric Delivery
88%
RNA Interference
77%
Lung
55%
Pulmonary Hypertension
55%
Antisense Oligonucleotide
55%
Combination Therapy
44%
Toxicity
33%
Lipid
22%
Intravenous Drug Administration
22%
Target Cell
22%
Small Interfering RNA
22%
Artery Disease
22%
Nanoparticle
22%
Cells
11%
Gene Expression
11%
Kidney
11%
Development
11%
Histopathology
11%
Leukocyte
11%
Tissues
11%
Diseases
11%
Cell Proliferation
11%
Liver
11%
Ethinylestradiol Plus Megestrol Acetate
11%
Serum
11%
in Situ Hybridization
11%
Cell Survival
11%
microRNA
11%
Spleen
11%
Heart Function
11%
Cell Fate
11%
Semaxanib
11%
Experimental Pulmonary Hypertension
11%
Pulmonary Vascular Disease
11%
RNAi Therapeutics
11%
Hypoxia-Induced Pulmonary Hypertension
11%
Gross Pathology
11%
Blood
11%
Biochemistry, Genetics and Molecular Biology
Oligonucleotide
66%
MicroRNA
55%
Antisense
55%
Rat
44%
Mir-145
44%
Electric Potential
22%
Lipid
22%
Target Cell
22%
Small Interfering RNA
22%
Gene Expression
11%
Development
11%
Mouse
11%
Leukocytes
11%
Experiment
11%
Cell Proliferation
11%
Cell Survival
11%
in Situ Hybridization
11%
Cell Fate
11%
Heart Function
11%
microRNA
11%
Blood Cell Count
11%
Pharmacology, Toxicology and Pharmaceutical Science
microRNA 145
100%
Pulmonary Hypertension
55%
Antisense Oligonucleotide
55%
Rat
44%
Toxicity
33%
Lipid
22%
Small Interfering RNA
22%
Artery Disease
22%
Diseases
11%
Mouse
11%
Oligonucleotide
11%
microRNA
11%
Ethinylestradiol Plus Megestrol Acetate
11%
Experimental Pulmonary Hypertension
11%
Semaxanib
11%
Hypoxia-Induced Pulmonary Hypertension
11%
Pulmonary Vascular Disease
11%